중앙대학교병원 | 의료진 상세정보(최세영)

학력

중앙대학교 대학원 의학박사
중앙대학교 대학원 의학석사
중앙대학교 의과대학 학사

경력 및 연수

중앙대학교병원 비뇨의학과 부교수
중앙대학교병원 비뇨의학과 조교수
중앙대학교병원 비뇨의학과 임상조교수
중앙대학교병원 비뇨의학과 임상조교수 대우
서울아산병원 임상조교수
서울아산병원 임상강사 (비뇨기종양학)
중앙대학교병원 비뇨의학과 레지던트
중앙대학교병원 인턴

수상내역

중앙대학교의료원 PR상
대한전립선학회 감사장
중앙대학교병원 개원56주년 표창장
대한비뇨의학회 국제학술대회 KUA2024 BEST 연제발표상 수상
2024 대한전립선학회-아시아태평양비뇨종양학회 공동국제심포지엄 우수포스터상
2024 의료데이터중심병원 지원 사업 24 CDM(Baseline DAta Base) 활용 경진대회 대상 수상
제 22회 대한비뇨기종양학회 우수논문 학술상
2023년 대한비뇨의학회 우수논문상 및 최다인용 논문상
제31회 대한전립선학회 정기학술대회 우수 논문상
제30회 대한전립선학회 정기학술대회 최우수학술상
제34회 대한비뇨기종양학회 정기학술대회 우수학술상
대한수술감염학회 학술대회 우수연제학술상
중앙대학교병원 고객만족 BEST상
의생명연구원 융합연구 심포지엄 장려상
대한비뇨기초음파학회 춘계학술대회 학술상
제 6회 중앙대학교병원 열정상
제 28회 대한전립선학회 정기학술대회 우수논문상
서울아산병원 우수의학논문표창장
대한전립선학회 우수학술상

학회활동

대한비뇨의학회 정회원

대한전립선학회 정회원

대한비뇨기종양학회 정회원

대한노인의학 세부전문의

비뇨초음파인증의

질병관리청 국가건강정보포털 건강정보 집필 및 감수위원

(구) 대한전립선학회 연구(기초)위원회 위원

(구) 대한전립선학회 국제교류위원회 위원

(구) 대한비뇨기종양학회 학회지 편집위원

(구) 요로생식기손상재건연구회 정책위원회 위원

(구) 요로생식기감염학회 제12대 이사

(구) 요로생식기감염학회 특수감염분과 위원

(구) 대한비뇨기종양학회 정보위원

(현) 대한비뇨의학회 비뇨내시경실인증제 위원

(구) 대한전립선학회 부총무

(구) 대한비뇨내시경로봇학회 WCET준비위원회

(구) 대한비뇨초음파학회 부총무

(구) 대한항노화비뇨통합연구회 진료지침이사

(구) 대한노인요양비뇨의학회 학회발전 TFT 위원

(현) 대한전립선학회 제14대 PCWG부단장

(현) 제10대 비뇨기초의학연구회 정보이사

(현) 대한항노화비뇨통합연구회 개원의협력위원회 이사

(현) 대한비뇨기종양학회 간행위원회위원, 기초연구위원회, 홍보위원회

(현) 대한비뇨의학회 비뇨내시경실인증제 위원

(현) 대한비뇨의학회 연구개발사업단 위원

(현) 대한비뇨의학회 진료지침개발위원회 부이사

논문 및 저서

1. Jung SH, Choi SY, Kim JY, Lee SH, Chung JD, Choi JW, et al. Temporary Vena Cava Filter Placement to Prevent Tumor Emboli During Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma. Chung-Ang journal of medicine. 2010;35(3):61-6.

2. Choi SY, Chang IH, Kim YS, Kim TH, Kim W, Myung SC. Prostate specific antigen velocity per prostate volume: a novel tool for prostate biopsy prediction. Urology. 2011;78(4):874-9.

3. Choi SY, Kim TH, Myung SC, Moon YT, Kim KD, Kim YS, et al. Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades. Korean journal of urology. 2012;53(1):23-8.

4. Chung JD, Choi SY, Lee SH, Myung SC. Etiology of Prostatic Reactivation of Embryonic Growth Pathways 1: Chronic Inflammation. Korean J Urol Oncol. 2012;10(01):13-20.

5. Lee SH, Jung HS, Choi SY, Chung JD, Lee JH, Ko KS, et al. The Correlation between Metabolic Syndrome and Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms. Korean J Urol Oncol. 2012;10(02):70-82.

6. Choi SY, Myung SC, Kim KD, Lee TJ. Ureteral Small Cell Carcinoma: A Case Report. Korean J Urol Oncol. 2012;10(02):97-100.

7. Choi SY, Ryu JH, Chang IH, Kim TH, Myung SC, Moon YT, et al. Predicting recurrence and progression of non-muscle-invasive bladder cancer in Korean patients: a comparison of the EORTC and CUETO models. Korean journal of urology. 2014;55(10):643-9.

8. Kwon JK, Chi BH, Choi SY, Kim SJ, Lee TJ, Kim K, et al. Murine beta-defensin-2 may regulate the effect of bacillus Calmette-Guerin (BCG) in normal mouse bladder. Urologic oncology. 2015;33(3):111 e9-16.

9. Choi SY, Kim HJ, Cheong HS, Myung SC. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population. Korean journal of urology. 2015;56(1):19-30.

10. Choi SY, Kim SJ, Chi BH, Kwon JK, Chang IH. Modulating the internalization of bacille Calmette-Guerin by cathelicidin in bladder cancer cells. Urology. 2015;85(4):964 e7- e12.

11. Choi SY, Chang IH. Predicting Recurrence and Progression of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors. Korean J Urol Oncol. 2015;13(1):01-10.

12. Choi SY, Chang IH. Molecular Defense Mechanisms during Urinary Tract Infection. Urogenit Tract Infect. 2015;10(2):57-66.

13. Yoo S, Choi SY, You D, Kim CS. New drugs in prostate cancer. Prostate international. 2016;4(2):37-42.

14. Choi SY, Ahn SH, Choi JD, Kim JH, Lee BI, Kim JI, et al. Determination of optimal imaging settings for urolithiasis CT using filtered back projection (FBP), statistical iterative reconstruction (IR) and knowledge-based iterative model reconstruction (IMR): a physical human phantom study. The British journal of radiology. 2016;89(1058):20150527.

15. Choi SY, Lee SY, Chi BH, Kim JW, Kim TH, Chang IH. Urbanization may affect the incidence of urolithiasis in South Korea. SpringerPlus. 2016;5(1):1891.

16. Chi BH, Chang IH, Choi SY, Suh DC, Chang CW, Choi YJ, et al. Daily Mean Temperature and Urolithiasis Presentation in Six Cities in Korea: Time-Series Analysis. Journal of Korean medical science. 2017;32(6):999-1008.

17. Choi SY, Yoon CG. Urologic Diseases in Korean Military Population: a 6-year Epidemiological Review of Medical Records. Journal of Korean medical science. 2017;32(1):135-42.

18. Choi SY, Yoo S, You D, Jeong IG, Song C, Hong B, et al. Adaptive functional change of the contralateral kidney after partial nephrectomy. American journal of physiology Renal physiology. 2017:ajprenal 00058 2017.

19. Choi SY, Yoo S, You D, Jeong IG, Song C, Hong B, et al. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma. Clinical genitourinary cancer. 2017.

20. Choi SY, Yoo S, Han JH, Jeong IG, Hong B, Hong JH, et al. Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients. International journal of surgery. 2017;47:101-6.

21. Nam W, Choi SY, Yoo SJ, Ryu J, Lee J, Kyung YS, et al. Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer. Investigative and clinical urology. 2018;59(1):18-24.

22. Han JH, Choi SY, Yoo S, Baek SH, Ryu J, Kyung YS, et al. Impact of Histologic Variants of Bladder Cancer on Oncology Outcome After Radical Cystectomy. The Korean Journal of Urological Oncology. 2017;15(3):121-30.

23. Choi SY, Ryu J, You D, Jeong IG, Hong JH, Ahn H, et al. Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study. Journal of cancer research and clinical oncology. 2018.

24. Kim DH, Shin JH, Choi SY, You D, Kim CS, Park HK. In vitro, in vivo, and clinical tests of a novel flexible ureteroscope for the diagnosis and treatment of kidney and ureteral diseases. Investigative and clinical urology. 2018;59(5):328-34.

25. Choi SY, Ryu J, You D, Hong JH, Ahn H, Kim CS. Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification. International journal of urology : official journal of the Japanese Urological Association. 2018.

26. Choi SY, Ryu J, You D, Jeong IG, Hong JH, Ahn H, et al. Prognostic factors of oncologic outcomes in metastatic chemotherapy-naive castration-resistant prostate cancer treated with enzalutamide in actual clinical practice in East Asia. Urologic oncology. 2018;36(9):401 e11- e18.

27. Lee W, Choi SY, Lee C, Yoo S, You D, Jeong IG, et al. Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma? Investigative and clinical urology. 2018;59(6):357-62.

28. Choi SY, Jung H, You D, Jeong IG, Song C, Hong B, et al. Robot-assisted partial nephrectomy is associated with early recovery of renal function: Comparison of open, laparoscopic, and robot-assisted partial nephrectomy using DTPA renal scintigraphy. Journal of surgical oncology. 2019.

29. Kwon WA, Joung JY, Lee JE, Choi SY, Kim SH, Seo HK, et al. Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study. Investigative and clinical urology. 2019;60(3):195-201.

30. Choi SY, Lim B, Kyung YS, Kim Y, Kim BM, Jeon BH, et al. Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance. In vivo. 2019;33(5):1615-20.

31. Choi SY, You D, Hong B, Hong JH, Ahn H, Kim CS. Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far? Surgical oncology. 2019;30:109-16.

32. Hwang GW, Choi SY, Chang IH. The Systematic Review of the Efficacy and Safety of Immune Checkpoint Inhibitor in Urological Cancers. Korean J Urol Oncol. 2019;17(2):75-80.

33. Choi SY, Chi BH, Lim B, Kyung YS, You D, Jeong IG, et al. Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer. Journal of cancer research and clinical oncology. 2020;146(2):537-43.

34. Choi SY, Chi BH, Kim TH, Lim B, Lee W, You D, et al. Does intraoperative frozen section really predict significant positive surgical margins after robot-assisted laparoscopic prostatectomy? A retrospective study. Asian journal of andrology. 2020.

35. Choi SY, Chi BH, Lee W, Lim B, You D, Kim CS. Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer. Journal of clinical medicine. 2020;9(5).

36. Choi SY, Kim TH. Survival strategy of urology department during the COVID-19 era. International urology and nephrology. 2020.

37. Kweon OJ, Lim YK, Kim HR, Lee M-K, Lee TJ, Won H, et al. Robot-Assisted Partial Nephrectomy for Treatment of Juxtaglomerular Cell Tumor of the Kidney: A Case Report. Journal of Endourology Case Reports. 2020;6(2):77-9.

38. Choi SY, Lim B, Chi BH, Kim JH, Lee W, Kyung YS, et al. Efficacy and tolerability of metallic stent in patients with malignant prostatic obstruction secondary to prostatic cancer. Low Urin Tract Symptoms. 2021;13(3):329-34.

39. Choi SY, Lim B, Chi BH, Kim JH, Lee W, You D, et al. Hybrid ileal pouch with concomitant anti-refluxing and refluxing ureteroileal anastomosis. BMC Urol. 2021;21(1):92.

40. Choi SY, Lim B, Chi BH, Lee W, Kim JH, Kyung YS, et al. The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer. Medicine (Baltimore). 2021;100(31):e26833.

41. Kim JH, Lee S, Kang SJ, Choi YW, Choi SY, Park JY, et al. Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette-Guerin. Int J Mol Sci. 2021;22(16).

42. Lim B, Choi SY, Kyung YS, You D, Jeong IG, Hong JH, et al. Value of clinical parameters and MRI with PI-RADSV2 in predicting seminal vesicle invasion of prostate cancer. Scand J Urol. 2021;55(1):17-21.

43. Yu YD, Ko YH, Kim JW, Jung SI, Kang SH, Park J, et al. The Prognosis and Oncological Predictor of Urachal Carcinoma of th e Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up. Front Oncol. 2021;11:683190.

44. Shim JH, Choi SY, Gook JH, Kim Y-J, Cha WH, Kim DH, et al. Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study. Urogenit Tract Infect. 2021;16(1):8-15.

45. Hong SJ, Hwang GY, Kang SJ, Choi SY, Chi BH, Chang IH. The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model. Korean J Urol Oncol. 2021;19(1):40-7.

46. Lee JW, Kim J, Shin Y, Chi BH, Kim JH, Choi SY. Patient-Specific Tumor Microenvironment Models. Korean J Urol Oncol. 2021;19(4):197-222.

47. Choi SY, Kim HH, Lim B, Lee JW, Kim YS, Kim JK, et al. Construction of a Retrospective Cohort to Observe 10-Year Urologic Cancer Treatment Trends at the Biggest Medical Center of South Korea. Korean J Urol Oncol. 2021;19(4):232-43.

48. Yoo S, Lim B, Choi SY, You D, Kim CS. Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome? Prostate international. 2021;9(3):119-24.

49. Choi SY, Ha MS, Chi BH, Kim JW, Chang IH, Kim TH, et al. Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study. Journal of cancer research and clinical oncology. 2022.

50. Choi SY, Ha MS, Kim JH, Chi BH, Kim JW, Chang IH, et al. Low-dose versus standard-dose bacille Calmette-Guerin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials. Investigative and clinical urology. 2022;63(2):140-50.

51. Kim JH, Choi J, Kim M, Kang SJ, Choi YW, Choi SY, et al. Immunotherapeutic effects of recombinant Bacillus Calmette-Guerin containing sic gene in ex vivo and in vivo bladder cancer models. Investigative and clinical urology. 2022;63(2):228-37.

52. Choi SY, Ha MS, Lee JW, Kim JH, Kim JH, Chi BH, et al. Shifting role of cytoreductive nephrectomy according to type of systemic therapy: A nationwide cohort study. Asian J Surg. 2022.

53. Tae JH, Ha MS, Chi BH, Chang IH, Kim TH, Myung SC, et al. Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study. BMC Urol. 2022;22(1):175.

54. Ha JB, Jeong J, Suh J, Park S, Wang RT, Kim T, et al. Artificial Intelligence on Urology Lab. Korean J Urol Oncol. 2022;20(3):163-76.

55. Lee YS, Ha MS, Tae JH, Chang IH, Kim TH, Myung SC, et al. Gemcitabine-cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study. Sci Rep. 2023;13(1):3682.

56. Song SH, Lee J, Ko YH, Kim JW, Jung SI, Kang SH, et al. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer : Stage-Matched Analysis of a Large Multicenter National Cohort. Cancer Res Treat. 2023.

57. Hyun J, Ha MS, Oh SY, Tae JH, Chi BH, Chang IH, et al. Urinary tract infection after radiation therapy or radical prostatectomy on the prognosis of patients with prostate cancer: a population-based study. BMC Cancer. 2023;23(1):395.

58. Choi J, Jung TY, Kim JH, Maeng S, Kang SJ, Kim M, et al. Efficacy of recombinant Bacillus Calmette-Guerin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model. Investigative and clinical urology. 2023;64(3):296-305.

59. Ahn IY, Ha MS, Kim WJ, Bae TH, Kim SM, Choi SY, et al. Rare Case of Managing and Evaluating Viability after Replantation of a Serial Self-Amputated Bilateral Testis by a Patient with Schizophrenia: A Case Report. Urol Int. 2023;107(8):827-34.

60. Lee YS, Kim SH, Tae JH, Chang IH, Kim TH, Myung SC, et al. Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials. Prostate international. 2023;11(3):159-66.

61. Shim JH, Choi SY, Chang IH, Park SB. Dose Optimization Using a Deep Learning Tool in Various CT Protocols for Urolithiasis: A Physical Human Phantom Study. Medicina (Kaunas). 2023;59(9).

62. Kim SH, Tae JH, Chang IH, Kim TH, Myung SC, Nguyen TT, et al. Changes in patient perceptions regarding ChatGPT-written explanations on lifestyle modifications for preventing urolithiasis recurrence. Digit Health. 2023;9:20552076231203940.

63. Nguyen TT, Dobbs RW, Vuong HG, Quy K, Ngo HTT, Mai AT, et al. Single-port and multiport robot-assisted radical prostatectomy: A meta-analysis. Prostate international. 2023;11(4):187-94.

64. Choi J, Kim JW, Lee YS, Tae JH, Choi SY, Chang IH, et al. Availability of ChatGPT to provide medical information for patients with kidney cancer. Sci Rep. 2024;14(1):1542.

65. Kim JS, Lee J, Nguyen TT, Choi SY. Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer. Sci Rep. 2024;14(1):8440.

66. Choi J, Kim KH, Kim HS, Yoon HS, Kim JH, Kim JW, et al. Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guerin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study. Investigative and clinical urology. 2024;65(3):248-55.

67. Choi SY, Kim Y, Lim B, Wee CB, Chang IH, Kim CS. Prostate cancer therapy using immune checkpoint molecules to target recombinant dendritic cells. Investigative and clinical urology. 2024;65(3):300-10.

68. Choi SY. Emergence of Novel Mechanisms in Erectile Dysfunction Treatment. World J Mens Health. 2024.

69. Lee D, Lim B, Nguyen TT, Choi SY. Identifying Suitable Patients for Overcoming Androgen Deprivation Monotherapy in De Novo Metastatic Hormone-Sensitive Prostate Cancer. J Pers Med. 2024;14(5).

70. Lee JY, Lee YS, Tae JH, Chang IH, Kim TH, Myung SC, et al. Selection of Convolutional Neural Network Model for Bladder Tumor Classification of Cystoscopy Images and Comparison with Humans. J Endourol. 2024;38(10):1036-43.

71. Yang YJ, Yang EJ, Choi SY. Scoping review exploring advancements in topical agent therapies for erectile dysfunction. Sex Med Rev. 2024;12(4):731-8.

72. Yang YJ, Lee YS, Tae JH, Choi J, Kim JH, Yang EJ, et al. Salvage lymphadenectomy or radiation therapy in prostate cancer patients with biochemical recurrence and PET positive lymph nodes after radical prostatectomy: A systematic review and pooled analysis. Eur J Surg Oncol. 2024;50(12):108704.

73. Duong NX, Thai MS, Tran NS, Hoang KC, Chau QT, Ngo XT, et al. The Impact of Socioeconomic Factors on Kidney Transplantation: A Systematic Review of Low-and Middle-Income Countries. Société Internationale d’Urologie Journal. 2024;5(5):349-60.

<저서>

‘신장 초음파 검사와 신장 조직 검사’ 대한비뇨초음파학회 2022.5.29. Chapter ‘외상에서의 신장 초음파 영상’

‘요로생식기감염’ 2판, 2022.4.22., Chapter ‘폴리도뇨관 관련 요로감염’ & Chapter ‘임신 중 요로감염’

‘Prostate Ultrasound and Biopsy of the Prostate’ 대한비뇨기초음파학회 2020.8.2., Chapter ‘Prostate anatomy’

‘Kidney Cancer: Recent Advances in Surgical and Molecular Pathology’ Springer, 2019.11.27., Chapter ‘Surgical Consideration in Renal Tumors’

‘Management of Advanced Prostate Cancer’ Springer, 2018.7.4., Chapter ‘Neoadjuvant Therapy Prior to Radical Prostatectomy’

‘전립선암의 기초연구’, 2016.4.30., 전립선암 기초 연구자모임, Medical Observer, The role of obesity & plant bioactive components in prostate cancer.

기타(관심분야 등)

[학회발표]

2024 데이터 활용 경진대회 (2024.11.05. 중앙대학교병원)

1. CDM을 이용한 전립선수술 방법에 따른 효과 및 안정성 비교 연구 (Podium)

2024 의생명연구원 심포지엄 (2024.11.05. 온라인)

1. 신장 및 상부요관 결석 체외충격파쇄석술에서 증강현실 기반 3D 모델 적용 (Podium)

KUA 2024 (2024.10.16.-18. 코엑스)

1. Selection of convolutional neural network model for bladder tumor classification of cystoscopy images and comparison with humans (Podium)

2. Beyond Biochemical Recurrence: Salvage for PET-Positive Lymph Node after Radical Prostatectomy (Podium)

3. Clinical Efficacy and Safety of Silodosin in Women with Lower Urinary Tract Symptoms: A 12-Week Prospective Study (Podium)

4. Clinical Outcomes and Costs of Robot-Assisted Versus Other Radical Prostatectomy for Prostate Cancer in South Korea: A Nationwide Comparison (Podium)

5. What Improvements Does Rezum Bring to BPH Management? Network Meta-Analysis Comparing Water Vapor Therapy and Conductional Techniques (Podium)

UAA2024 (2024.09.05.-08. 인도네시아 발리)

1.Beyond Biochemical Recurrence: Salvage for PET-Positive Lymph Node after Radical Prostatectomy (Moderated Poster)

2024KPS (2024.08.30.-31. 분당서울대학교병원 헬스케어혁신파크)

1. Clinical Efficacy and Safety of Silodosin in Women with Lower Urinary Tract Symptoms: A 12-Week Prospective Study (Poster)

2. What Improvements Does Rezum Bring to BPH Management? Network Meta-Analysis Comparing Water Vapor Therapy and Conductional Techniques (Poster)

3. Beyond Biochemical Recurrence: Salvage for PET-Positive Lymph Node after Radical Prostatectomy (Poster)

4. Clinical Outcomes and Costs of Robot-Assisted Versus Other Radical Prostatectomy for Prostate Cancer in South Korea: A Nationwide Comparison (Poster)

2024년 제37회 대한비뇨기종양학회 정기학술대회 (2024.08.31. 차바이오컴플렉스)

1. Beyond Biochemical Recurrence: Salvage for PET-Positive Lymph Node after Radical Prostatectomy (Oral)

EAU24 (2024.04.05.-08. 프랑스 파리)

1. Dose optimization by deep learning tool in various CT protocols for urolithiasis: a physical human phantom study (Moderated Poster)

2024 KPS (2024.03.08.-09. SC컨벤션)

1.Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials (Podium)

[강의]

1. 전국 비뇨기과 전공의 1년차 대상 ‘� �상 봉합 및 관리 강의’ (아산병원 동관6층 5세미나실, 2017.3.2)

2. 아산병원병동 간호사 대상 ‘비뇨기계수술의 이해 강의’ (아산병원 신관11층 병동회의실, 2017.6.20)

3. 2018 제 29차 중앙의대 비뇨의학과 동문회 워크숍 ‘Hematuria 접근 최신 지견’ (중앙대학교 병원 4층 대강의실, 2018.6.9)

4. 2019년 대한요로생식기감염학회 워크샵 ‘2019년 융합연구그룹 proposal 보고 및 연구방향’ (중앙대학교 병원 4층 대강의실, 2019.2.23)

5. 8th Young Forum ‘Combination of Chemotherapy or New Agents(Xtandi or Abiraterone) with ADT’ (인천 그랜드하얏트호텔 그랜드볼룸, 2019.5.25~26)

6. Together Symposium ‘한국 급여 기준에 따른 mRCC 및 metastatic urothelial cancer 약제 사용’ (인천 네스트호텔 Baum Hall A, 2019.6.29~30)

7. 문영태교수님 정년 송사강의 ‘한국 급여 기준에 따른 비뇨의학과 신장, 방광, 전립선 전이암 치료‘ (중앙대학교병원 다정관4층 강의실, 2019.8.5)

8. 제6회 RCC SUMMIT ‘Prognostic models and markers update: can we improve risk startification?’ (서울아산병원 연구원 지하 소강당, 2019.8.31)

9. 2019 KPS-APSU Joint International Symposium ‘GnRH Agonist in Prostate Cancer’ (한양대학교 HIT, 2019.9.6~7)

10. 제3회 대한비뇨국소치료연구회 학술대회 ‘Follow up’ (삼성서울병원 암병원 B1 대강당, 2019.10.25)

11. 제1회 대한비뇨내시경로봇학회 로봇수술연구회 심포지움 ‘My initial experience and questions for RNUx (semi-live)’ (고려대학교 의과대학 최덕경강의실, 2020.1.10)

12. 2020 Prostate Cancer Summit ‘Experimental Prostate Cancer Models: Beyond the Mouse’ (웨스틴조선서울호텔, 2020.7.11)

13. 제6회 대한비뇨통학의학연구회 심포지움 ‘Microbiome in Urologic Non-malignancy Disease’ (대전인터시티호텔, 2020.7.18)

14. 안국약품 사내강의 ‘에이케어와 관련된 배뇨장애 질환’ (온라인강의, 2020.7.30)

15. 한미약품 온라인강의 ‘Treatment dose of tamsulosin in LUTS/BPH : Unmet needs and real world experience for tamsulosin 0.4 mg’ (온라인강의, 2020.8.10)

16. 2020 With symposium ‘Optimal treatment strategies for LUTS associated with BPH using tamsulosin 0.2mg or higher dose’ (그랜드 하얏트 인천, 2020.10.25)

17. 2020 중앙의대 비뇨융합 세미나 ‘유전자 재조합 BCG 및 Gemcitabine에 대한 연구’ (코트야드 메리어트 서울 보타닉파크호텔, 2020.12.04)

18. 2021년 제7회 대한비뇨통합의학연구회 온라인 심포지움 ‘Microbiome in Urologic Non-malignancy Disease’ (온라인강의, 2021.01.16)

19. 제11회 서울아산병원 로봇수술 심포지엄 ‘Robot-assisted radical nephroureterectomy’ (온라인강의, 2021.02.20)

20. Uro-Pharm Symposium ‘Prostate inflammation & the action of phyto-therapy’ (홀리데이 인 인천 송도, 2021.05.23)

21. Takeda Lucid-Prime Symposium ‘Recent prostate cancer study in Korea’ (인터컨티넨탈 서울 코엑스, 2021.6.4)

22. 2021년 대한항노화비뇨통합연구회 심포지엄 ‘Effect of Early Enteral Nutrition after GU Surgery’ (차바이오컴플렉스 대강당, 2021.7.17)

23. 2021년 대한골반통학회 제9차 학술대회 및 연수강좌 ‘Interstitial cystitis’ (온라인강의, 2021.9.5)

24. 2021 BLUE 심포지엄 ‘Neoadjuvant therapy in high risk prostate cancer’ (인천 그랜드하얏트호텔, 2021.9.25)

25. KUA 2021 ‘Survival tip of first year staff in a hospital’ (서울 COEX, 2021.11.3)

26. 2021 대한비뇨초음파학회 추계학술대회 ‘The standards of transabdominal US for the examination of the BPH and the assessment of the PVR’ (세종대학교 대양관 AI홀, 2021.11.27)

27. 동아제약 사내강의 ‘Erectile dysfunction & Zydena’ (온라인강의, 2021.12.2)

28. 2021 중앙의대 비뇨융합 및 오가노이드 세미나 ‘Organ on a Chip을 이용한 drug screening’ (코트야드 메리어트 서울 보타닉파크호텔, 2021.12.3.)

29. 2022년 대한항노화비뇨통학연구회 심포지엄 ‘Statin Therapy to Improve Prostate Cancer Outcomes: Who, When, and for How Long?’ (차바이오컴플렉스, 2022.01.15.)

30. 2022 Alvogen Prostate Cancer Symposium ‘Should ADT be combined with radiotherapy in treating BCR after radical prostatectomy and GETUG-AFU16 STUDY’ (코트야드메리어트서울판교, 2022.03.04.)

31. 2022 전립선암 가이드라인 심포지엄 ‘Definition and management of RP failure: What we can do for adverse features?’ (백범김구기념관, 2022.06.04.)

32. 2022 AU Symposium ‘Appropriate treatment in BCR after RP’ (경주 힐튼호텔, 2022.06.17.)

33. 한미약품 온라인강의 ‘Ideal LUTS/BPH treatment Focusing on Patients Aspects’ (온라인강의, 2022.08.18.)

34. 2022 KPS-APSU Joint International Symposium ‘Prevention of the Skeletal-Related Event with a Bone Protecting Agent for Patients with Bone Metastatic CRPC’ (SC컨벤션센터, 2022.09.03.)

35. FKR x CKD Symposium ‘Real Life Practice ‘Add on therapy desmopressin on BPH drug treatment’ (인터컨티넨탈 서울 코엑스, 2022.09.19.)

36. KUA2022 ‘Indications for Cystoscopy and Findings’ (코엑스, 2022.10.07.)

37. TOGETHER SYMPOSIUM ‘Recent studies and effectiveness of silodosin’ (그랜드 하얏트 인천, 2022.10.15.)

38. 2022 제9회 대한남성과학회-대한전립선학회 공동심포지엄 ‘Should we do PSA screening, biopsy, and prostate cancer treatment in Elderly Patient?’ (롯데호텔 울산, 2022.10.21.)

39. A♡U Symposium ‘Statin in Urologic Cancer’ (라한셀렉트 경주, 2022.11.05.)

40. 2022년 중앙의대 비뇨융합 및 오가노이드 세미나 ‘Immune checkpoint molecules-targeting recombinant dendritic cells for therapeutic effect on prostate cancer’ (중앙대학교광명병원, 2022.11.11.)

41. 임상노인의학회 ‘노인의 배뇨장애’ (온라인, 2022.11.17.)

42. 제4차 대한비뇨의학회 KUA R&D Workshop ‘The effect of apalutamide on mCSPC compared to other androgen receptor signaling inhibitors: network MA of RCTs’ (베스트웨스턴프리미어 강남, 2022.11.24.)

43. 2022년 항노화-재생의학협회 추계 심포지엄 ‘Combining androgen receptor targeted agents (ARTA) with ADT in mHSPC’ (건양대학교 죽헌정보관, 2022.11.26.)

44. 일양약품 Web Symposium ‘Terazosin and bethanechol in LUTS’ (온라인, 2023.01.27.)

45. 2023년 제4회 대한항노화비뇨통합연구회 심포지엄 ‘Complementary and Alternative Medicine (CAM) Supplements in Cancer Outpatients’ (차바이오컴플렉스, 2023.01.28.)

46. J STAR Symposium 2023 ‘가이드라인 속 알파차단제와 트루패스의 의의’ (인천 그랜드하얏트호텔, 2023.2.25.)

47. Handok web-symposium ‘고령 환자의 과민성 방광 증상 조절을 위한 약제 선택의 기준’ (온라인, 2023.5.8.)

48. 2023 서울아산병원 비뇨기암센터 심포지엄: 요로상피암 ‘Preoperative evaluation (ureteroscopy-related debates)’ (서울아산병원 연구원 지하소강당, 2023.5.13.)

49. 2023년 제33차 중앙대학교 비뇨의학과 워크샵 ‘SDT update’ (중앙대학교광명병원, 2023.5.20.)

50. 2023년 블루심포지엄 ‘Surgery of oligometastatic prostate cancer’ (롤링힐스, 2023.5.27.)

51. 2023년 항노화-재생의학 협회 춘계 심포지엄 ‘The function, mechanisms, and clinical applications of metformin’ (UNIST, 2023.6.2.)

52. 2023 대한전립선암가이드라인 심포지엄 ‘Real clinical advantage of neoadjuvant ADT before radical prostatectomy’ (백범김구기념관, 2023.6.10.)

53. 2023 제13회 대한배뇨장애요실금학회 대한전립선학회 공동 심포지엄 ‘Recent Update on LUTS/BPH (l) Work-up & Diagnosis’ (세종충남대학교병원, 2023.7.22.)

54. 시공연하 아스텔라스 미팅 ‘ AUA 2023 Updates prostate cancer’ (압구정루위, 2023.8.22.)

55. 2023 6th URO-PHARM SYMPOSIUM ‘PSA screening 관련 최신 지견전립선암의 진단 등’ (라마다앙코르바이윈덤김포한강호텔, 2023.8.27.)

56. 2023 KPS-APSU Joint International Symposium ‘Optimal treatment strategies for high- or very high-risk NMIBC: intravesical treatment or upfront cystectomy’ (SC컨벤션센터, 2023.9.1.)

57. Astellas Urology Webinar ‘노인의 배뇨장애와 베타미가’ (온라인, 2023.9.12.)

58. Alvogen Prostate Cancer Webinar ‘How to improve treatment outcomes in hihg-risk PC patients?’ (온라인, 2023.10.5.)

59. 2023년도 추계 서울아산병원 비뇨기암센터 심포지엄 ‘Luciferase tagged hormone sensitive prostate cancer cell lines for bone metastatic prostate cancer animal model’ (서울아산병원 연구원지하대강당, 2023.10.28.)

60. 2023년 항노화-재생의학 협회 추계 심포지엄 ‘Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update’ (세종충남대학교병원 본관4층 도담홀, 2023.10.28.)

61. 2023년 대한비뇨의학회 전공의 e-learning ‘전립선암의 진단 첫 걸음’ (코엑스 녹화, 2023.11.01.)

62. KUA2023 Satellite Luncheon Symposium 8 ‘My first experience on urological surgery with newly advanced VEIII’ (코엑스, 2023.11.03.)

63. 2023 중앙의대 비뇨융합 및 오가노이드 세미나 ‘Anti-cancer effects of sonodynamic therapy in bladder cancer’ (중앙대학교광명병원, 2023.11.10.)

64. 2023 제4회 전립선암연구회 연구워크샵 Research Day ‘Reluctant usage of ADT in mHSPC’ (세종대학교 대양AI센터 12층 AI홀, 2023.11.11.)

65. 2024 제6회 Prostate Cancer Summit ‘PSMA-PET Utilization in PC diagnostics’ (삼성생명 일원역빌딩 히포크라테스홀, 2024.01.13.)

66. 2024년 제6회 대한항노화비뇨통합연구회 심포지엄 ‘What is healthy food with enlarged prostate?’ (서울성모병원 본관 지하1층 대강당, 2024.01.20.)

67. 2024 비뇨기초의학연구회 요로생식기 손상재건연구회 공동학술대회 ‘Immune checkpoint molecule-targeting recombinant dendritic cells for therapeutic effect on prostate cancer’ (신촌세브란스 암병원 지하3층 서암강당, 2024.02.24.)

68. J Star Symposium ‘여성LUTS환자 대상 트루패스 임상 결과 발표’ (호텔나루, 2024.02.24.)

69. T.O.P Webinar ‘실로도신의 여성 LUTS 환자 대상 임상 결과 발표 및 여성 배뇨장애 치료 전략’ (온라인, 2024.03.05.)

70. URO Round Table Meeting ‘액티클랏 소개 및 Case 발표’ (그랜드하얏트서울, 2024.03.12.)

71. 2024 The 1st BPH Innovation Forum ‘Detrusor Underactivity in men in retention: BPH surgery or not’ (이대서울병원, 2024.04.20.)

72. LUCID Prime Symposium ‘Systemic treatment for men with high-risk and locally-advanced prostate cancer’ (소피텔 앰배서더 서울, 2024.05.10.)

73. 2024 Prostate Cancer Forum: Guidelines and Consensus ‘What are my own methods to prevent incontinence after radical prostatectomy? 1. Techniques during RP’ (백범김구기념관, 2024.06.01.)

74. 제34차 중앙대학교 비뇨의학과 워크샵 ‘요로결석 대사이상’ (중앙대학교광명병원, 2024.06.01.)

75. 2024 제 7회 대한항노화비뇨통합연구회 심포지엄 ‘Calroic Restriction May Prevent Age Related Impairment of Bladder Function?’ (울산대학교병원, 2024.07.20.)

76. 2024년 제14회 대한전립선학회-대한배뇨장애요실금학회 공동심포지엄 ‘Recent Update on LUTS/BPH – Medical treatment’ (순천향대학교부속 천안병원, 2024.07.27.)

77. 2024년 제14회 대한전립선학회-대한배뇨장애요실금학회 공동심포지엄 ‘Why is Abiraterone therapy important in the treatment of metastatic prostate cancer?’ (순천향대학교부속 천안병원, 2024.07.27.)

78. Zometa Ready with advanced convenience ‘Prevention of the skeletal-related event with a bone protecting agent for patients with bone metastatic CRPC’ (Oakwood Premier Coex Seoul, 2024.08.21.)

79. 2024 KPS in conjunction with APSU joint International Symposium ‘Management of recurrent low-grade intermediate-risk bladder cancer despite intravesica l chemotherapy or BCG’ (분당서울대학교병원 헬스케어혁신파크, 2024.08.30.)

80. 한독 자트랄 웨비나 ‘alpha-blocker treatment considering side effects and efficacy’ (온라인, 2024.09.24.)

81. 2024년 제11회 대한남성과학회-대한전립선학회 공동심포지엄 ‘BPH Surgery in Men

with Detrusor Underactivity: To Do or Not to Do’ (대구가톨릭대학교 의과대학 루가관, 2024.10.11.)

82. KUA2024 Satellite Luncheon Symposium 5 ‘Why is Abiraterone therapy important in the treatment of metastatic prostate cancer?’ (코엑스, 2024.10.17.)

83. 2024 중앙의대 비뇨융합 및 오가노이드 의학연구소 세미나 ‘비뇨기암에 대한 빅데이터’ (중앙대학교광명병원, 2024.11.15.)

84. 전립선암연구회 웨비나 ‘The Power of Over 10 Years of Experience on ZYTIGA’ (온라인, 2024.11.28.)

구분	금 01	토 02	일 03	월 04	화 05	수 06	목 07	금 08	토 09	일 10	월 11	화 12	수 13	목 14	금 15	토 16	일 17	월 18	화 19	수 20	목 21	금 22	토 23	일 24	월 25	화 26	수 27	목 28	금 29	토 30	일 31
오전
오후